Overview

Study Of Cabaser and Sinemet CR For The Treatment Of Nighttime Symptoms Associated With Parkinson's Disease.

Status:
Terminated
Trial end date:
2005-09-01
Target enrollment:
Participant gender:
Summary
The study will assess the relative benefit of cabergoline vs carbidopa/levodopa therapy in treating nighttime problems of Parkinson Disease.
Phase:
Phase 4
Details
Lead Sponsor:
Pfizer
Treatments:
Cabergoline
Carbidopa
Carbidopa, levodopa drug combination
Levodopa